AR074354A1 - Alquilciclohexileteres de dihidrotetraazabenzoazulenos, procesos de preparacion y composiciones farmaceuticas que los contienen - Google Patents
Alquilciclohexileteres de dihidrotetraazabenzoazulenos, procesos de preparacion y composiciones farmaceuticas que los contienenInfo
- Publication number
- AR074354A1 AR074354A1 ARP090104427A ARP090104427A AR074354A1 AR 074354 A1 AR074354 A1 AR 074354A1 AR P090104427 A ARP090104427 A AR P090104427A AR P090104427 A ARP090104427 A AR P090104427A AR 074354 A1 AR074354 A1 AR 074354A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- substituted
- unsubstituted
- alkoxy
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Los compuestos de la solicitud actúan como moduladores del receptor de la V1a y en particular como antagonistas del receptor de la V1a; la solicitud se refiere además a su obtención, a las composiciones farmacéuticas que los contienen y a su utilización como medicamentos. Los compuestos activos de la presente son útiles como agentes terapéuticos que actúan a nivel periférico y central en estados patológicos de la dismenorrea, disfunción sexual masculina o femenina, hipertensión, fallo cardiaco crónico, secreción inapropiada de vasopresina, cirrosis hepática, síndrome nefrótico, ansiedad, trastornos depresivos, trastorno obsesivo-compulsivo, trastornos del espectro autista, esquizofrenia y comportamiento agresivo. Reivindicación 1: El compuesto de la fórmula (1) en la que R1 es alquilo C1-12, sin sustituir o sustituido por uno o más halógeno, hidroxi, ciano o alcoxi C1-12, cicloalquilo C3-7 sin sustituir o sustituido por uno o más sustituyentes elegidos con independencia entre sí entre B, heterocicloalquilo de 4-7 eslabones que contiene uno o dos heteroátomos elegidos entre O, N y S; dicho heterocicloalquilo está sin sustituir o sustituido por uno o más sustituyentes elegidos con independencia entre B; R2 es H, alquilo C1-12, sin sustituir o sustituido por uno o más OH, halógeno, ciano o alcoxi C1-12, -(CH2)q-Ra, en el que Ra es fenilo o heteroarilo de 5 o 6 eslabones, cada uno de ellos está sin sustituir o sustituido por uno o más sustituyentes elegidos con independencia entre A, -(CH2)rNRiRii, -C(O)-alquilo C1-12, dicho alquilo está sin sustituir o sustituido por uno o más OH, halógeno, ciano o alcoxi C1-12; -C(O)(CH2)qOC(O)-alquilo C1-12, -C(O)(CH2)qNRiRii, -C(O)O-alquilo C1-12, dicho alquilo está sin sustituir o sustituido por uno o más OH, halógeno, ciano o alcoxi C1-12, -S(O)2-alquilo C1-12, -S(O)2NRiRii; Ri y Rii con independencia entre sí son H, alquilo C1-12, o junto con el átomo de N al que están unidos forman un heterocicloalquilo de 3 a 7 eslabones que contiene uno o dos heteroátomos elegidos entre N, O y S, dicho heterocicloalquilo está sin sustituir o sustituido por uno o más sustituyentes elegidos con independencia entre sí entre B, q es el número 1, 2, 3 o 4; r es el número 2, 3 o 4; A es halógeno, ciano, OH, alquilo C1-7, halo-alquilo C1-7 o alcoxi C1-7; B es oxo, halógeno, OH, alquilo C1-7 o alcoxi C1-7, R3 es Cl o F; o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08169348 | 2008-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR074354A1 true AR074354A1 (es) | 2011-01-12 |
Family
ID=41398220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090104427A AR074354A1 (es) | 2008-11-18 | 2009-11-16 | Alquilciclohexileteres de dihidrotetraazabenzoazulenos, procesos de preparacion y composiciones farmaceuticas que los contienen |
Country Status (25)
Country | Link |
---|---|
US (1) | US8642590B2 (es) |
EP (1) | EP2358714B1 (es) |
JP (1) | JP5384659B2 (es) |
KR (1) | KR101385433B1 (es) |
CN (1) | CN102216304B (es) |
AR (1) | AR074354A1 (es) |
AU (1) | AU2009317386B2 (es) |
BR (1) | BRPI0921058A2 (es) |
CA (1) | CA2739900C (es) |
CL (1) | CL2011001129A1 (es) |
CY (1) | CY1113692T1 (es) |
DK (1) | DK2358714T3 (es) |
ES (1) | ES2391374T3 (es) |
HR (1) | HRP20120816T1 (es) |
IL (1) | IL212119A (es) |
MX (1) | MX2011005119A (es) |
PE (1) | PE20110590A1 (es) |
PL (1) | PL2358714T3 (es) |
PT (1) | PT2358714E (es) |
RU (1) | RU2510397C2 (es) |
SG (1) | SG171742A1 (es) |
SI (1) | SI2358714T1 (es) |
TW (1) | TWI389911B (es) |
WO (1) | WO2010057795A1 (es) |
ZA (1) | ZA201102604B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2356123T1 (sl) | 2008-11-13 | 2013-01-31 | F. Hoffmann-La Roche Ag | Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni |
SG171742A1 (en) | 2008-11-18 | 2011-07-28 | Hoffmann La Roche | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes |
EP2370441B1 (en) | 2008-11-28 | 2013-09-11 | F. Hoffmann-La Roche AG | Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin v1a receptor antagonists |
US8420633B2 (en) * | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8461151B2 (en) * | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
US8492376B2 (en) | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8481528B2 (en) | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8513238B2 (en) | 2010-05-10 | 2013-08-20 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
US8828989B2 (en) * | 2011-09-26 | 2014-09-09 | Hoffmann-La Roche Inc. | Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists |
EP2763997B1 (en) * | 2011-10-05 | 2017-08-02 | F. Hoffmann-La Roche AG | Cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
MX2016006558A (es) * | 2013-12-05 | 2016-08-03 | Hoffmann La Roche | Sistesis de trans-8-cloro-5-metil-1-[4-(piridin-2-iloxi)-ciclohexi l]-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo[e]azuleno y formas cristalinas del mismo. |
WO2017191117A1 (en) | 2016-05-03 | 2017-11-09 | Bayer Pharma Aktiengesellschaft | V1a receptor antagonists for use in the treatment of renal diseases |
CN108329051B (zh) * | 2017-07-04 | 2020-09-18 | 中国科学院金属研究所 | 一种超高孔隙率和低坯体收缩率Y2SiO5多孔陶瓷的制备方法 |
CA3079133A1 (en) * | 2017-12-08 | 2019-06-13 | F. Hoffmann-La Roche Ag | Pharmaceutical formulation |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521173A (en) | 1995-01-17 | 1996-05-28 | American Home Products Corporation | Tricyclic benzazepine vasopressin antagonists |
US7138393B2 (en) * | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
HU229074B1 (en) * | 1999-01-19 | 2013-07-29 | Ortho Mcneil Pharm Inc | Tricyclic benzodiazepines as vasopressin receptor antagonists |
TWI239333B (en) * | 2000-11-16 | 2005-09-11 | Hoffmann La Roche | Benzodiazepine derivatives as GABA A receptor modulators |
US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
GB0303852D0 (en) * | 2003-02-19 | 2003-03-26 | Pfizer Ltd | Triazole compounds useful in therapy |
EA200801812A1 (ru) | 2003-09-17 | 2009-06-30 | Янссен Фармацевтика Н.В. | Сопряженные гетероциклические соединения |
GB0400700D0 (en) * | 2004-01-13 | 2004-02-18 | Pfizer Ltd | Compounds useful in therapy |
JP4085178B2 (ja) * | 2004-05-17 | 2008-05-14 | アステラス製薬株式会社 | 縮合ベンズアゼピン誘導体の新規製造法 |
AP2006003768A0 (en) * | 2004-05-25 | 2006-10-31 | Pfizer Prod Inc | TetraazabenzoÄeÜazulene derivatives and analogs tehereof |
KR100840852B1 (ko) | 2004-05-25 | 2008-06-23 | 화이자 프로덕츠 인크. | 테트라아자벤조[e]아줄렌 유도체 및 이의 유사체 |
EP1632494A1 (en) | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
MX2007002248A (es) * | 2004-08-25 | 2008-10-02 | Pfizer | Triazolobenzodiazepinas y su uso como antagonistas de vasopresina. |
EP1861102A1 (en) | 2005-03-15 | 2007-12-05 | F. Hoffmann-Roche AG | Use of 2-anilino-3,4-dihydro-quinazolines as 5ht5a receptor antagonists |
US20080188478A1 (en) | 2005-04-26 | 2008-08-07 | Pfizer Inc. | Compounds Useful In Therapy |
CA2608718A1 (en) | 2005-05-18 | 2006-11-23 | Pfizer Limited | 1, 2, 4-triazole derivatives as vasopressin antagonists |
KR101129791B1 (ko) | 2007-01-12 | 2012-03-23 | 에프. 호프만-라 로슈 아게 | 스파이로피페리딘 글리신아마이드 유도체 |
SG171742A1 (en) | 2008-11-18 | 2011-07-28 | Hoffmann La Roche | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes |
US8420633B2 (en) * | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8461151B2 (en) * | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
US8492376B2 (en) * | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8481528B2 (en) * | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8513238B2 (en) | 2010-05-10 | 2013-08-20 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
-
2009
- 2009-11-09 SG SG2011035474A patent/SG171742A1/en unknown
- 2009-11-09 PT PT09747861T patent/PT2358714E/pt unknown
- 2009-11-09 ES ES09747861T patent/ES2391374T3/es active Active
- 2009-11-09 JP JP2011535980A patent/JP5384659B2/ja active Active
- 2009-11-09 PL PL09747861T patent/PL2358714T3/pl unknown
- 2009-11-09 CA CA2739900A patent/CA2739900C/en not_active Expired - Fee Related
- 2009-11-09 CN CN200980146033.4A patent/CN102216304B/zh active Active
- 2009-11-09 DK DK09747861.4T patent/DK2358714T3/da active
- 2009-11-09 BR BRPI0921058A patent/BRPI0921058A2/pt not_active IP Right Cessation
- 2009-11-09 RU RU2011121438/04A patent/RU2510397C2/ru not_active IP Right Cessation
- 2009-11-09 PE PE2011000978A patent/PE20110590A1/es not_active Application Discontinuation
- 2009-11-09 EP EP09747861A patent/EP2358714B1/en active Active
- 2009-11-09 AU AU2009317386A patent/AU2009317386B2/en not_active Ceased
- 2009-11-09 MX MX2011005119A patent/MX2011005119A/es active IP Right Grant
- 2009-11-09 WO PCT/EP2009/064804 patent/WO2010057795A1/en active Application Filing
- 2009-11-09 SI SI200930344T patent/SI2358714T1/sl unknown
- 2009-11-09 KR KR1020117011201A patent/KR101385433B1/ko not_active IP Right Cessation
- 2009-11-12 US US12/616,805 patent/US8642590B2/en active Active
- 2009-11-16 TW TW098138877A patent/TWI389911B/zh not_active IP Right Cessation
- 2009-11-16 AR ARP090104427A patent/AR074354A1/es unknown
-
2011
- 2011-04-04 IL IL212119A patent/IL212119A/en not_active IP Right Cessation
- 2011-04-07 ZA ZA2011/02604A patent/ZA201102604B/en unknown
- 2011-05-15 CL CL2011001129A patent/CL2011001129A1/es unknown
-
2012
- 2012-10-10 CY CY20121100936T patent/CY1113692T1/el unknown
- 2012-10-11 HR HRP20120816AT patent/HRP20120816T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR074354A1 (es) | Alquilciclohexileteres de dihidrotetraazabenzoazulenos, procesos de preparacion y composiciones farmaceuticas que los contienen | |
AR074409A1 (es) | Derivados de arilciclohexileteres de 5,6-dihidro-4h-2,3,5,10-b-tetraaza-benzo[e]azuleno, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos en disfunciones sexuales y trastornos del snc, entre otras patologias. | |
AR081374A1 (es) | Heteroaril-ciclohexil-tetraazabenzo[e]azulenos | |
AR080927A1 (es) | Heteroaril-ciclohexil-tetraazabenzo[e]azulenos como antagonistas del receptor de v1a y un proceso para su obtencion | |
AR074317A1 (es) | Espiro-5,6 dihidro -4h-2,3,5,10b-tetraaza-benzo(e)azulenos | |
AR080955A1 (es) | Aril-/heteroaril-ciclohexenil-tetraazabenzo(e)azulenos | |
AR080733A1 (es) | Aril-ciclohexil-tetraazabenzo[e]azulenos, un proceso para su obtencion, una composicion farmaceutica que los contiene y su uso para la preparacion de un medicamento para el tratamiento de enfermedades mediadas por el antagonismo del receptor de v1a | |
AR066904A1 (es) | Pirrolopiridinas y pirazolopiridinas sustituidas como moduladores de las quinasas, una composicion farmaceutica que las incluye y su uso en el tratamiento del cancer | |
CO2017011174A2 (es) | Derivados de etileno como moduladores metabotropicos de receptores de glutamato | |
AR078756A1 (es) | Moduladores alostericos positivos (map) | |
AR075051A1 (es) | Compuestos antidiabeticos que contienen ftalazina | |
AR085149A1 (es) | Moduladores del receptor de glucagon | |
AR081182A1 (es) | Heterobiaril-ciclohexil-tetraazabenzo[e]azulenos | |
AR070395A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il- amina | |
AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
AR075049A1 (es) | Compuestos antidiabeticos que contienen pentafluorsulfolano | |
AR078495A1 (es) | Compuestos policiclicos como antagonistas del receptor de acido lisofosfatidico | |
AR065622A1 (es) | Derivados de 3-ciano -4- (4-fenil- piperidin -1- il) piridin -2- ona | |
AR074459A1 (es) | Pirrolopirazinil-ureas utiles para el tratamiento de enfermedades autoinmunes e inflamatorias. | |
AR056560A1 (es) | Pirrolopiridinonas como moduladores cb1 | |
AR075150A1 (es) | Compuestos antidiabeticos en puente y fusionados | |
AR075597A1 (es) | Derivados de indol como antagonistas de receptores crth2, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del asma y otras enfermedades alergicas . | |
AR074965A1 (es) | Compuestos antidiabeticos heterociclicos puenteados y fusionados | |
AR048789A1 (es) | Derivados de oxazol y sus composiciones como moduladores de receptor activado de proliferador de peroxisoma (ppar) | |
AR080083A1 (es) | Moduladores de gamma-secretasa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |